AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
Managing Cardiac Amyloidosis and Rhythm Disturbances
This chapter explores the challenges of managing cardiomyopathy and associated rhythm disturbances in patients with amyloidosis, emphasizing individualized treatment approaches and the importance of anticoagulation. It discusses afterload reduction, beta blockers, and the investigational horizon of monoclonal antibodies like tammamab, calium antibodies, and the atralis program in treating amyloidosis. The chapter underscores the critical role of early diagnosis, collaboration between cardiologists and hematologists, and timely referral to major centers and clinical trials for effective management of amyloidosis patients.